You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
山東新華製藥股份(00719.HK)全資子公司獲得藥品註冊證書
格隆匯 03-08 16:44

格隆匯 3 月 8日丨山東新華製藥股份(00719.HK)公佈,近日,公司全資子公司—山東淄博新達製藥有限公司("新達製藥")收到國家藥品監督管理局核准簽發的乳酸菌素顆粒(1g)和乳酸菌素顆粒(2g)《藥品註冊證書》,該產品通過新產品註冊審評("新產品註冊")。

據悉,乳酸菌素為脱脂牛乳發酵處理後,由乳酸菌在代謝過程中通過核糖體合成機制產生的一類具有抑菌活性的多肽、蛋白質或蛋白質複合物,除此之外還有乳糖、半乳糖、乳酸、礦物質,尚有微量的卵磷脂、膽固醇、檸檬酸、色素、氣體、維生素和酶等營養物質。它可在腸道形成保護層,通過四種作用機制阻礙病原菌、病毒對機體的侵襲:一是刺激腸道分泌抗體、提高腸道免疫力;二是選擇性殺死腸道致病菌,保護促進有益菌的生長;三是調節腸黏膜電解質、水分平衡;四是促進胃液分泌,增強消化功能。臨牀上主要用於腸內異常發酵,消化不良,腸炎和小兒腹瀉等,本品為OTC乙類藥品,多年以來應用證明,乳酸菌素療效確切、安全性好,獲得廣大患者的好評。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account